Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

IGC Pharma, Inc. Common Stock (NY:IGC)

0.4337 -0.0043 (-0.98%)
Official Closing Price Updated: 8:00 PM EDT, Sep 5, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about IGC Pharma, Inc. Common Stock

< Previous 1 2
...
13 14 15 16 17 18 19 20 Next >
420 with CNW — Schumer Promises to Fight for Federal Cannabis Decriminalization in 2023
Via Investor Brand Network
Topics Cannabis
BioMedNewsBreaks – India Globalization Capital Inc. (NYSE American: IGC) Set to Begin IGC-AD1 Phase 2 Trials at Sites Throughout Canada
Via Investor Brand Network
IGC Expanding Clinical Trials Of THC Based Drug Following Approval From Health Canada
India Globalization Capital, Inc. (AMEX:IGC) has received a no objection letter from Health Canada for approval of its trial, “A phase 2, multi-center, double-blind, randomized, placebo-controlled... 
Via Benzinga
420 with CNW — Kentucky Prepares to Implement Medical Cannabis Executive Order
Via Investor Brand Network
Topics Cannabis Law Enforcement
420 with CNW — Kentucky Prepares to Implement Medical Cannabis Executive Order
Via CannabisNewsWire
Topics Cannabis Law Enforcement
Research Discovers Bidirectional Link Between Lower-Back Pain, Insomnia
Via Investor Brand Network
420 with CNW — Bipartisan Legislators Call on Biden to Support Cannabis Legalization
Via CannabisNewsWire
Topics Cannabis
420 with CNW — Bipartisan Legislators Call on Biden to Support Cannabis Legalization
Via Investor Brand Network
Topics Cannabis
420 with CNW — DOJ Official Explains Upcoming Process to Gain Presidential Marijuana Pardon
Via Investor Brand Network
Topics Cannabis Lawsuit
420 with CNW — DOJ Official Explains Upcoming Process to Gain Presidential Marijuana Pardon
Via CannabisNewsWire
Topics Cannabis Lawsuit
BioMedNewsBreaks – India Globalization Capital Inc. (NYSE American: IGC) Files Updated Life Sciences Presentation
Via Investor Brand Network
Topics Regulatory Compliance
420 with CNW — Canadian Medical Marijuana Companies Target Patients with Health Cover
Via Investor Brand Network
Topics Cannabis
420 with CNW — Canadian Medical Marijuana Companies Target Patients with Health Cover
Via CannabisNewsWire
Topics Cannabis
420 with CNW — FDA Seeks More Data in Fight Against Delta-8 THC Products
Via Investor Brand Network
Topics Cannabis Derivatives
420 with CNW — FDA Seeks More Data in Fight Against Delta-8 THC Products
Via CannabisNewsWire
Topics Cannabis Derivatives
Research Links Diets High in Fat to Chronic Pain
Via Investor Brand Network
420 with CNW — DOJ Requests Additional Time in Cannabis Consumption Sites Case
Via Investor Brand Network
Topics Cannabis Government Law Enforcement
420 with CNW — DOJ Requests Additional Time in Cannabis Consumption Sites Case
Via CannabisNewsWire
Topics Cannabis Government Law Enforcement
420 with CNW — Colorado Regulators Allow Medical Cannabis to Be Recategorized as Recreational Marijuana
Via CannabisNewsWire
Topics Cannabis
420 with CNW — Colorado Regulators Allow Medical Cannabis to Be Recategorized as Recreational Marijuana
Via Investor Brand Network
Topics Cannabis
Existing Drug May Alleviate Side Effects of Cancer Treatment
Via Investor Brand Network
420 with CNW — New Study Finds Medical Cannabis Legalization Reduces Use of Opioids by Cancer Patients
Via Investor Brand Network
Topics Cannabis
420 with CNW — New Study Finds Medical Cannabis Legalization Reduces Use of Opioids by Cancer Patients
Via CannabisNewsWire
Topics Cannabis
CannabisNewsBreaks – India Globalization Capital Inc. (NYSE American: IGC) Applauds Milestone Development for Medical Cannabis Industry
Via Investor Brand Network
Topics Cannabis
CannabisNewsBreaks – India Globalization Capital Inc. (NYSE American: IGC) Applauds Milestone Development for Medical Cannabis Industry
Via CannabisNewsWire
Topics Cannabis
BioMedNewsBreaks – India Globalization Capital Inc. (NYSE American: IGC) Commences Trial Evaluating IGC-AD1 for the Treatment of Alzheimer’s-Related Symptoms
Via Investor Brand Network
BioMedNewsBreaks – India Globalization Capital Inc. (NYSE American: IGC) to Present at RHK 2022 Disruptive Growth Conference
Via Investor Brand Network
IGC Starts Phase 2 Clinical Trials Of THC Based Drug Candidate For The Treatment Of Agitation In Dementia From Alzheimer's Disease
India Globalization Capital, Inc. (AMEX:IGC) has begun “A phase 2, multi-center, double-blind, randomized, placebo-controlled, trial of the safety and efficacy of IGC-AD1 on agitation in participants... 
Via Benzinga
IGC Commences Phase 2 Clinical Trials Evaluating Drug Candidate IGC-AD1 for the Treatment of Agitation in Dementia From Alzheimer’s Disease
From India Globalization Capital, Inc.
Via Business Wire
InvestorNewsBreaks – India Globalization Capital Inc. (NYSE American: IGC) Releases Financial Numbers for Q2
Via Investor Brand Network
Topics Intellectual Property
< Previous 1 2
...
13 14 15 16 17 18 19 20 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.